Carnegie Investment Counsel’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.2M Buy
333,786
+29,297
+10% +$3.62M 0.74% 33
2025
Q4
$38.3M Sell
304,489
-36,043
-11% -$4.7M 0.71% 32
2025
Q3
$49.8M Buy
340,532
+21,563
+7% +$3.26M 0.94% 23
2025
Q2
$49.7M Buy
318,969
+170,549
+115% +$27M 1% 18
2025
Q1
$22.1M Sell
148,420
-6,525
-4% -$1.09M 0.53% 57
2024
Q4
$25.2M Sell
154,945
-1,631
-1% -$292K 0.72% 34
2024
Q3
$30.6M Sell
156,576
-1,001
-0.6% -$184K 0.9% 27
2024
Q2
$27.3M Sell
157,577
-22,316
-12% -$3.71M 0.85% 30
2024
Q1
$30.4M Buy
179,893
+5,833
+3% +$1.09M 0.95% 21
2023
Q4
$34.4M Buy
174,060
+1,527
+0.9% +$270K 1.18% 15
2023
Q3
$30M Buy
172,533
+6,540
+4% +$1.19M 1.15% 15
2023
Q2
$28.6M Buy
165,993
+2,888
+2% +$499K 1.06% 19
2023
Q1
$27.1M Buy
163,105
+2,786
+2% +$457K 1.08% 17
2022
Q4
$23.5M Buy
160,319
+5,020
+3% +$743K 1.01% 19
2022
Q3
$23M Sell
155,299
-2,650
-2% -$443K 1.1% 16
2022
Q2
$27.1M Sell
157,949
-4,725
-3% -$817K 1.23% 14
2022
Q1
$30.7M Buy
162,674
+455
+0.3% +$89.9K 1.12% 15
2021
Q4
$39.6M Buy
162,219
+35
+0% +$7.67K 1.31% 11
2021
Q3
$31.5M Sell
162,184
-1,556
-1% -$314K 1.18% 16
2021
Q2
$30.5M Sell
163,740
-4,993
-3% -$867K 1.15% 17
2021
Q1
$26.6M Buy
168,733
+3,592
+2% +$569K 1.11% 17
2020
Q4
$27.3M Buy
165,141
+5,325
+3% +$866K 1.23% 16
2020
Q3
$26.4M Buy
159,816
+4,700
+3% +$722K 1.35% 14
2020
Q2
$21.2M Sell
155,116
-245
-0.2% -$32K 1.22% 16
2020
Q1
$18.2M Sell
155,361
-2,330
-1% -$307K 1.27% 14
2019
Q4
$20.9M Sell
157,691
-973
-0.6% -$121K 1.2% 14
2019
Q3
$19.8M Sell
158,664
-1,975
-1% -$238K 1.26% 14
2019
Q2
$18.2M Sell
160,639
-962
-0.6% -$101K 1.19% 19
2019
Q1
$16.3M Sell
161,601
-5,303
-3% -$481K 1.12% 19
2018
Q4
$14.3M Sell
166,904
-59,767
-26% -$5.38M 1.33% 14
2018
Q3
$20.9M Buy
226,671
+58,663
+35% +$5.2M 1.72% 9
2018
Q2
$15.4M Buy
168,008
+3,667
+2% +$310K 1.17% 20
2018
Q1
$13.9M Sell
164,341
-1,983
-1% -$156K 1.16% 23
2017
Q4
$12.3M Sell
166,324
-2,817
-2% -$193K 1.09% 21
2017
Q3
$11M Sell
169,141
-2,120
-1% -$133K 1.29% 18
2017
Q2
$10.5M Sell
171,261
-3,964
-2% -$234K 1.28% 17
2017
Q1
$10.5M Buy
175,225
+8,207
+5% +$443K 1.3% 14
2016
Q4
$9.01M Buy
167,018
+7,385
+5% +$375K 1.2% 18
2016
Q3
$7.99M Buy
159,633
+1,300
+0.8% +$65.8K 1.15% 21
2016
Q2
$7.89M Buy
158,333
+1,995
+1% +$94.2K 1.11% 23
2016
Q1
$6.92M Buy
156,338
+3,745
+2% +$159K 1.06% 28
2015
Q4
$6.57M Buy
152,593
+7,160
+5% +$324K 1.14% 28
2015
Q3
$6.21M Buy
145,433
+12,072
+9% +$560K 1.07% 28
2015
Q2
$6.43M Sell
133,361
-435
-0.3% -$20.8K 1.12% 24
2015
Q1
$6.28M Buy
133,796
+3,882
+3% +$175K 1.08% 25
2014
Q4
$5.74M Buy
129,914
+1,095
+0.9% +$44.4K 1.08% 26
2014
Q3
$4.76M Sell
128,819
-4,149
-3% -$142K 0.95% 30
2014
Q2
$4.29M Sell
132,968
-4,701
-3% -$144K 0.98% 36
2014
Q1
$3.98M Buy
137,669
+2,220
+2% +$67.8K 1.05% 35
2013
Q4
$4.43M Buy
135,449
+9,051
+7% +$289K 1.19% 27
2013
Q3
$3.93M Buy
126,398
+103,734
+458% +$3.18M 1.21% 29
2013
Q2
$700K Buy
+22,664
New +$734K 0.23% 107

Other funds holding ZTS

Carnegie Investment Counsel's ZTS Position: Q1 2026 in Review

Carnegie Investment Counsel increased its Zoetis (ZTS) stake by 9.6% in Q1 2026, buying an estimated $3.62M and bringing the position to 333,786 shares worth $38.2M. The position accounts for 0.74% of the portfolio, ranked #33.

Carnegie Investment Counsel first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.8M in Q3 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Carnegie Investment Counsel held 333,786 shares of Zoetis worth $38.2M as of Q1 2026.
  • Carnegie Investment Counsel bought 29,297 Zoetis shares in Q1 2026, an estimated $3.62M.
  • Zoetis made up 0.74% of Carnegie Investment Counsel's portfolio in Q1 2026, its #33 holding.
  • Carnegie Investment Counsel first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
  • Carnegie Investment Counsel's Zoetis position peaked at $49.8M in Q3 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.